Back to Research Hub
Repligen Corporation
RGEN
$130.13+4.80 (+3.83%)
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.
StreetsValue research for Repligen Corporation (RGEN)
Members get the full report for Repligen Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.